Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$351M |
| 2 |
Netflix
NFLX
|
+$343M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$293M |
| 4 |
Nike
NKE
|
+$186M |
| 5 |
Delta Air Lines
DAL
|
+$177M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.33B |
| 2 |
Tesla
TSLA
|
+$344M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$306M |
| 4 |
NVIDIA
NVDA
|
+$281M |
| 5 |
Boeing
BA
|
+$251M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.45% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Cellectar Biosciences
CLRB
$16.9M
| $57K | ﹤0.01% |
723
-1,410
| -66% | -$111K |
|
3377
Castor Maritime
CTRM
$19.4M
| $57K | ﹤0.01% |
13,140
-940
| -7% | -$4.08K |
|
|
IMA
3378
ImageneBio, Inc. Common Stock
IMA
$103M
| $57K | ﹤0.01% |
1,091
-84
| -7% | -$4.39K |
|
|
SANW
3379
DELISTED
S&W Seed Co
SANW
| $57K | ﹤0.01% |
2,685
-179
| -6% | -$3.8K |
|
3380
Journey Medical
DERM
$193M
| $57K | ﹤0.01% |
20,900
+9,400
| +82% | +$25.6K |
|
|
CONN
3381
DELISTED
Conn's Inc.
CONN
| $57K | ﹤0.01% |
14,412
-145,400
| -91% | -$575K |
|
|
AAU
3382
DELISTED
Almaden Minerals Ltd.
AAU
| $57K | ﹤0.01% |
390,966
-267,430
| -41% | -$39K |
|
|
VRPX
3383
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
| $57K | ﹤0.01% |
284
-73
| -20% | -$14.7K |
|
3384
Zevia
ZVIA
$185M
| $56K | ﹤0.01% |
+25,200
| New | +$56K |
|
3385
InspireMD
NSPR
$101M
| $55K | ﹤0.01% |
16,700
+2,500
| +18% | +$8.23K |
|
3386
Sonnet BioTherapeutics
SONN
$27M
| $55K | ﹤0.01% |
2,381
+711
| +43% | +$16.4K |
|
|
MVLA
3387
DELISTED
Movella Holdings Inc. Common Stock
MVLA
| $55K | ﹤0.01% |
+102,045
| New | +$55K |
|
3388
Santander
BSBR
$40.7B
| $54K | ﹤0.01% |
10,500
-44,700
| -81% | -$230K |
|
3389
Myomo
MYO
$34M
| $54K | ﹤0.01% |
48,200
-38,698
| -45% | -$43.4K |
|
3390
Predictive Oncology
POAI
$10.9M
| $54K | ﹤0.01% |
16,876
-2,000
| -11% | -$6.4K |
|
|
TFFP
3391
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $54K | ﹤0.01% |
6,220
+2,200
| +55% | +$19.1K |
|
3392
Compass Therapeutics
CMPX
$606M
| $53K | ﹤0.01% |
+26,800
| New | +$53K |
|
3393
NexGel
NXGL
$19.9M
| $53K | ﹤0.01% |
25,031
-1,000
| -4% | -$2.12K |
|
|
VAPO
3394
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $53K | ﹤0.01% |
20,954
-7,187
| -26% | -$18.2K |
|
|
CWBR
3395
DELISTED
CohBar, Inc. Common Stock
CWBR
| $53K | ﹤0.01% |
17,160
+3,800
| +28% | +$11.7K |
|
|
MF
3396
DELISTED
Missfresh Limited American Depositary Shares
MF
| $53K | ﹤0.01% |
+58,147
| New | +$53K |
|
|
DPSI
3397
DELISTED
DecisionPoint Systems, Inc.
DPSI
| $52K | ﹤0.01% |
+10,475
| New | +$52K |
|
3398
Moleculin Biotech
MBRX
$11.4M
| $51K | ﹤0.01% |
8,013
-480
| -6% | -$3.06K |
|
3399
PepGen
PEPG
$44.3M
| $51K | ﹤0.01% |
+10,000
| New | +$51K |
|
3400
BiomX
PHGE
$13.5M
| $51K | ﹤0.01% |
14,463
-5,087
| -26% | -$17.9K |
|